Research progress on treatment strategies for simultaneous/staged percutaneous coronary intervention in patients with severe aortic valve stenosis and chronic coronary artery disease undergoing percutaneous aortic valve replacement surgery
10.3969/j.issn.1004-8812.2024.05.007
- VernacularTitle:重度主动脉瓣狭窄合并慢性冠状动脉疾病患者经导管主动脉瓣置换术同期/分期经皮冠状动脉介入治疗救治策略的研究进展
- Author:
Ling MA
1
;
Jing-Ya WANG
;
Qian-Wei XU
;
Xiao-Lin YU
Author Information
1. 新疆医科大学研究生学院,新疆乌鲁木齐 830001
- Keywords:
Aortic stenosis;
Transcatheter aortic valve replacement;
Percutaneous coronary intervention
- From:
Chinese Journal of Interventional Cardiology
2024;32(5):271-275
- CountryChina
- Language:Chinese
-
Abstract:
Currently,transcatheter aortic valve replacement(TAVR)is not only the preferred alternative for highrisk and severe aortic stenosis(AS)patients in surgery,but also benefits patients with moderate and lowrisk AS.Nearly half of AS patients have coronary artery disease(CAD),so percutaneous coronary intervention(PCI)has become a common clinical requirement in patients with severe AS combined with CAD treated with TAVR.There is significant controversy over which TAVR or PCI should be prioritized or conducted simultaneously.This article will review the timing of PCI treatment for severe AS patients with chronic CAD who undergo TAVR treatment.